Publication

Effectiveness of RESET: a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease

Vlagsma, T. T., Duits, A. A., Dijkstra, H. T., van Laar, T. & Spikman, J. M., 2020, In : Neuropsychological Rehabilitation. 30, 1, p. 67-84 18 p.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Vlagsma, T. T., Duits, A. A., Dijkstra, H. T., van Laar, T., & Spikman, J. M. (2020). Effectiveness of RESET: a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease. Neuropsychological Rehabilitation, 30(1), 67-84. https://doi.org/10.1080/09602011.2018.1452761

Author

Vlagsma, Thialda T. ; Duits, Annelien A. ; Dijkstra, Hilde T. ; van Laar, Teus ; Spikman, Jacoba M. / Effectiveness of RESET : a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease. In: Neuropsychological Rehabilitation. 2020 ; Vol. 30, No. 1. pp. 67-84.

Harvard

Vlagsma, TT, Duits, AA, Dijkstra, HT, van Laar, T & Spikman, JM 2020, 'Effectiveness of RESET: a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease', Neuropsychological Rehabilitation, vol. 30, no. 1, pp. 67-84. https://doi.org/10.1080/09602011.2018.1452761

Standard

Effectiveness of RESET : a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease. / Vlagsma, Thialda T.; Duits, Annelien A.; Dijkstra, Hilde T.; van Laar, Teus; Spikman, Jacoba M.

In: Neuropsychological Rehabilitation, Vol. 30, No. 1, 2020, p. 67-84.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Vlagsma TT, Duits AA, Dijkstra HT, van Laar T, Spikman JM. Effectiveness of RESET: a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease. Neuropsychological Rehabilitation. 2020;30(1):67-84. https://doi.org/10.1080/09602011.2018.1452761


BibTeX

@article{46652268b250405d8ba075ba8a78afb7,
title = "Effectiveness of RESET: a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease",
abstract = "In this multicentre randomised controlled trial (RCT), 43 patients with Parkinson’s disease (PD) were randomly allocated to either the experimental condition receiving cognitive rehabilitation including strategy training (ReSET; Strategic Executive Treatment, n = 24) or to the control condition receiving computerised repetitive practice training for attention (Cogniplus, n = 16). We expected that strategy training (ReSET) would be more effective than cognitive training (Cogniplus) in improving patients’ everyday life executive functioning. Neuropsychological assessment was administered at baseline, at 2 weeks and 3–5 months post-treatment. Primary outcome measure was the Role Resumption List (RRL). Secondary outcome measures were treatment goal attainment (TGA), Dysexecutive Questionnaire (DEX), Parkinson’s Disease Questionnaire (PDQ-39), Zarit Burden Interview (ZBI) and neuropsychological tests. No effects of treatment were found on the primary outcome measure and on neuropsychological tests, except for one test of attention. At 2 weeks and 3–5 months post-treatment, PD patients in both the ReSET and Cogniplus group reported a significant improvement in everyday life executive functioning, as measured with TGA and the DEX-self, with an advantage for ReSET only shortly after treatment. Given these results and that PD patients were able to adhere to these treatments despite their motor symptoms and fatigue (i.e., the drop-out rate was small), we conclude that both strategy training and cognitive training for impairments in EF might be beneficial and feasible for PD patients.",
author = "Vlagsma, {Thialda T.} and Duits, {Annelien A.} and Dijkstra, {Hilde T.} and {van Laar}, Teus and Spikman, {Jacoba M.}",
year = "2020",
doi = "10.1080/09602011.2018.1452761",
language = "English",
volume = "30",
pages = "67--84",
journal = "Neuropsychological Rehabilitation",
issn = "0960-2011",
publisher = "ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD",
number = "1",

}

RIS

TY - JOUR

T1 - Effectiveness of RESET

T2 - a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease

AU - Vlagsma, Thialda T.

AU - Duits, Annelien A.

AU - Dijkstra, Hilde T.

AU - van Laar, Teus

AU - Spikman, Jacoba M.

PY - 2020

Y1 - 2020

N2 - In this multicentre randomised controlled trial (RCT), 43 patients with Parkinson’s disease (PD) were randomly allocated to either the experimental condition receiving cognitive rehabilitation including strategy training (ReSET; Strategic Executive Treatment, n = 24) or to the control condition receiving computerised repetitive practice training for attention (Cogniplus, n = 16). We expected that strategy training (ReSET) would be more effective than cognitive training (Cogniplus) in improving patients’ everyday life executive functioning. Neuropsychological assessment was administered at baseline, at 2 weeks and 3–5 months post-treatment. Primary outcome measure was the Role Resumption List (RRL). Secondary outcome measures were treatment goal attainment (TGA), Dysexecutive Questionnaire (DEX), Parkinson’s Disease Questionnaire (PDQ-39), Zarit Burden Interview (ZBI) and neuropsychological tests. No effects of treatment were found on the primary outcome measure and on neuropsychological tests, except for one test of attention. At 2 weeks and 3–5 months post-treatment, PD patients in both the ReSET and Cogniplus group reported a significant improvement in everyday life executive functioning, as measured with TGA and the DEX-self, with an advantage for ReSET only shortly after treatment. Given these results and that PD patients were able to adhere to these treatments despite their motor symptoms and fatigue (i.e., the drop-out rate was small), we conclude that both strategy training and cognitive training for impairments in EF might be beneficial and feasible for PD patients.

AB - In this multicentre randomised controlled trial (RCT), 43 patients with Parkinson’s disease (PD) were randomly allocated to either the experimental condition receiving cognitive rehabilitation including strategy training (ReSET; Strategic Executive Treatment, n = 24) or to the control condition receiving computerised repetitive practice training for attention (Cogniplus, n = 16). We expected that strategy training (ReSET) would be more effective than cognitive training (Cogniplus) in improving patients’ everyday life executive functioning. Neuropsychological assessment was administered at baseline, at 2 weeks and 3–5 months post-treatment. Primary outcome measure was the Role Resumption List (RRL). Secondary outcome measures were treatment goal attainment (TGA), Dysexecutive Questionnaire (DEX), Parkinson’s Disease Questionnaire (PDQ-39), Zarit Burden Interview (ZBI) and neuropsychological tests. No effects of treatment were found on the primary outcome measure and on neuropsychological tests, except for one test of attention. At 2 weeks and 3–5 months post-treatment, PD patients in both the ReSET and Cogniplus group reported a significant improvement in everyday life executive functioning, as measured with TGA and the DEX-self, with an advantage for ReSET only shortly after treatment. Given these results and that PD patients were able to adhere to these treatments despite their motor symptoms and fatigue (i.e., the drop-out rate was small), we conclude that both strategy training and cognitive training for impairments in EF might be beneficial and feasible for PD patients.

U2 - 10.1080/09602011.2018.1452761

DO - 10.1080/09602011.2018.1452761

M3 - Article

VL - 30

SP - 67

EP - 84

JO - Neuropsychological Rehabilitation

JF - Neuropsychological Rehabilitation

SN - 0960-2011

IS - 1

ER -

ID: 74503222